Product
Viral Specific T-cells
2 clinical trials
3 indications
Indication
Allogeneic Stem Cell TransplantIndication
viral infectionIndication
Organ TransplantClinical trial
A Randomized Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells (VSTs) for Control of Viral Infections After Allogeneic Stem Cell TransplantStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
Viral Specific T-cells (VSTs) for Treatment of Viral Infections After Solid Organ TransplantStatus: Active (not recruiting), Estimated PCD: 2024-09-01